The Food and Drug Administration has granted Fast Track designation to GNSC-001 for the treatment of osteoarthritis of the knee.
Injuries and osteoarthritis of the knee are common. Fortunately, there are many ways to prevent and treat knee pain.
VICTORIA, BC, Nov. 14, 2024 /PRNewswire/ - Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX) (NASDAQ: ...
Objectives Secondary prevention of rheumatoid arthritis (RA) is generally considered potentially impactful because the entire ...